Dealmaking in Asia is not going to be easy in 2020, especially in China. While uncertainty still hangs over the U.S.-China trade deal, the outbreak of the novel coronavirus that originated in China will further disrupt cross-border transactions.

Mergers and acquisitions in and out of China slowed in 2019 after the United States and China entered a new phase of contentious trade, economic and diplomatic relations. Bidders from mainland China and Hong Kong spent only $5.7 billion in the U.S. in 2019, the lowest total since 2011, according to data compiled by Mergermarket. Meanwhile, the total value of U.S. investment into China and Hong Kong dropped to $7.7 billion, the lowest since 2013.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]